Thymic hyperplasia in Graves' disease
- PMID: 23869315
- PMCID: PMC3712389
- DOI: 10.4103/2230-8210.111676
Thymic hyperplasia in Graves' disease
Abstract
Graves' disease is an autoimmune thyroid condition characterized by the production of autoantibodies against the thyrotropin receptor. It is known to be associated with autoimmune conditions such as myasthenia gravis, Addison's disease, type 1 diabetes mellitus, and vitiligo. We present a case of rare autoimmune association of Graves' disease with thymic hyperplasia which regressed after treatment with antithyroid drugs. Exact pathophysiology of thymic hyperplasia in Graves' is not well understood; it is likely to be the result of rather than the cause of Graves' disease.
Keywords: Antithyroid drugs; Graves’ disease; autoimmune condition; thymic hyperplasia.
Conflict of interest statement
Figures
References
-
- Zelissen PM, Bast EJ, Croughs RJ. Associated autoimmunity in Addison's disease. J Autoimmun. 1995;8:121–30. - PubMed
-
- Gunn A, Michie W, Irvine WJ. The thymus in thyroid disease. Lancet. 1964;2:776–8. - PubMed
-
- Hammar JA. [Kasuistischer Beitrag Zur frage nachdem Einfluss endokriner Erkrankungen, auf die Thymusdruse] Acta Med Scand. 1929;70:449–59.
-
- Michie W, Gunn A. The thyroid, the thymus and autoimmunity. Br J Clin Pract. 1966;20:9–13. - PubMed
-
- Bergman TA, Mariash CN, Oppenheimer JH. Anterior mediastinal mass in a patient with Graves’ disease. J Clin Endocrinol Metab. 1982;55:587–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources